As RSV cases surge at SoCal hospitals, vaccine might only be a year away
RSV cases in kids are surging in Southern California, but a Pfizer vaccine might be only a year away.Drugmaker Pfizer reports its RSV vaccine is safe for pregnant women and is effective in helping to protect their newborn babies.As health officials all over Southern California deal with an onslaught of viruses affecting mainly children, news of this potential vaccine offers hope on the horizon.
"We have surpassed the 5% threshold and the amount of influenza we're seeing is increasing sharply," said Dr. Muntu Davis, L.A. County's health officer. "This is the earliest start to the flu season we've experienced in the past five years." "This is good news because it provides a high level of protection during the period of life when infants are most vulnerable," said Dr. William Gruber, senior vice president of Pfizer vaccine clinical research and development.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
RSV Vaccine Protected Infants From Severe Cases, Pfizer Study FindsAn RSV vaccine given to pregnant women significantly reduced the risk of severe cases in their infants. The study comes as doctors report unusually high numbers of the respiratory illness.
Consulte Mais informação »
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data showsPfizer said it will submit an application to the Food and Drug Administration for the RSV vaccine's approval by the end of 2022.
Consulte Mais informação »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Consulte Mais informação »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Consulte Mais informação »
Pfizer announces promising developments for 1st maternal RSV vaccineAfter decades of researching respiratory syncytial virus, an illness especially dangerous for newborns and the elderly, scientists this week announced a major development in plans for a possible vaccine that could be available as soon as next year.
Consulte Mais informação »